Octinoxate
Protectives Against Uv-Radiation For Topical Use
Sold as PEPPERMINT · ZINC STICK · BLISTEX DCT · Note BB 500 · TEINT LUMIÈRE
- Drug class
- Protectives Against Uv-Radiation For Topical Use
- Availability
- Over-the-counter
- Routes
- Topical
- Markets covered
- 2
- Products on record
- 143
- FDA reports (12 mo)
- 8
Overview
Octinoxate is an active pharmaceutical ingredient in the Protectives Against Uv-Radiation For Topical Use group (D02BA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 70 | April 9, 2026 |
| CA Canada | Health Canada | 73 | February 20, 2026 |
USUnited States· FDA
70 products
Uses
Use Helps prevent sunburn. Higher SPF gives more sunburn protection. If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun.
How to take
CACanada· Health Canada
73 products
73 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [2].
Sources & citations
- [1]FDA DailyMed · 00281d57-4b60-44… · revised April 6, 2026 [PDF]
- [2]Health Canada (DPD) · 02035472 · revised March 22, 2025
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.